Product NDC: | 61314-238 |
Proprietary Name: | Carteolol Hydrochloride |
Non Proprietary Name: | Carteolol Hydrochloride |
Active Ingredient(s): | 10 mg/mL & nbsp; Carteolol Hydrochloride |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61314-238 |
Labeler Name: | Sandoz Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075476 |
Marketing Category: | ANDA |
Start Marketing Date: | 20000105 |
Package NDC: | 61314-238-10 |
Package Description: | 10 mL in 1 BOTTLE, PLASTIC (61314-238-10) |
NDC Code | 61314-238-10 |
Proprietary Name | Carteolol Hydrochloride |
Package Description | 10 mL in 1 BOTTLE, PLASTIC (61314-238-10) |
Product NDC | 61314-238 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Carteolol Hydrochloride |
Dosage Form Name | SOLUTION |
Route Name | OPHTHALMIC |
Start Marketing Date | 20000105 |
Marketing Category Name | ANDA |
Labeler Name | Sandoz Inc. |
Substance Name | CARTEOLOL HYDROCHLORIDE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |